KB Medical Group Inc is one of the key players in the needlestick safety injection devices market with 510K cleared safety needles and compatible with both luer slip and luer lock disposable syringe. We are very optimistic about the prospects of the safety injection devices market. To meet the rapidly growing customer demand and further reduce the product costs, the company has recently put into operation two more new assembly lines for safety hypodermic needle and safety insulin pen needle.
𝐓𝐡𝐞 𝐧𝐞𝐞𝐝𝐥𝐞𝐬𝐭𝐢𝐜𝐤 𝐬𝐚𝐟𝐞𝐭𝐲 𝐢𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟖%, 𝐭𝐢𝐥𝐥 𝟐𝟎𝟑𝟓.
Given the inherent benefits of needlestick safety injection devices, a number of developers have launched their proprietary devices for minimizing the risk of needlestick injuries. Currently, more than 50 companies claim to develop around 120 needlestick safety injection devices, globally. Moreover, stringent regulatory requirements have further prompted the stakeholders to improve product design and integrate better safety measures in their products, including needle shielding. In fact, more than 140 patents needlestick safety injection devices have been filed / granted by various academic and industry stakeholders, since 2018. (Source from Roots Analysis)